The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia (2013)
Source: Naunyn-Schmiedeberg's Archives of Pharmacology. Unidade: FMRP
Subjects: DOR, ARTICULAÇÕES, NEUTRÓFILOS (METABOLISMO), DOENÇAS IMUNOLÓGICAS, MODELOS ANIMAIS DE DOENÇAS
ABNT
GUERRERO, Ana T. et al. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 386, n. 1, p. 51-59, 2013Tradução . . Disponível em: https://doi.org/10.1007/s00210-012-0813-4. Acesso em: 22 ago. 2024.APA
Guerrero, A. T., Zaperlon, A. C., Vieira, S. M., Pinto, L. G., Ferreira, S. H., Cunha, F. de Q., et al. (2013). The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn-Schmiedeberg's Archives of Pharmacology, 386( 1), 51-59. doi:10.1007/s00210-012-0813-4NLM
Guerrero AT, Zaperlon AC, Vieira SM, Pinto LG, Ferreira SH, Cunha F de Q, Verri Junior WA, Cunha TM. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 1): 51-59.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00210-012-0813-4Vancouver
Guerrero AT, Zaperlon AC, Vieira SM, Pinto LG, Ferreira SH, Cunha F de Q, Verri Junior WA, Cunha TM. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 1): 51-59.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00210-012-0813-4